发明名称 |
ANTITHROMBOTIC AMIDINOPHENYLALANINE AND AMIDINOPYRIDYLALANINE DERIVATIVES |
摘要 |
Compounds of formula (I), pharmaceutically acceptable salt thereof, and pharmaceutically acceptable solvates of either entity, wherein X is CH or N; Y is optionally monounsaturated C3-C5 alkylene optionally substituted with C1-C4 alkyl or methylene; R<1> is H; C1-C4 alkyl optionally substituted with C1-C4 alkoxy, OH, NR<5>R<6>, CONR<5>R<6>, C3-C6 cycloalkyl or aryl; or C3-C6 alkenyl; R<2> is H; C1-C4 alkyl optionally substituted with C1-C4 alkoxy, OH, NR<5>R<6>, CONR<5>R<6>, C3-C6 cycloalkyl or aryl; or CONR<5>R<6>; R<3> and R<4> are each independently selected from H; C1-C4 alkyl optionally substituted with NR<5>R<6>; C1-C4 alkoxy; halo; CONR<5>R<6> and aryl; R<5> and R<6> are each independently selected from H and C1-C4 alkyl; and m and n are each independently 1, 2 or 3; are potent and selective thrombin inhibitors useful in the treatment of, <u>inter alia</u>, deep vein thrombosis; reocclusion following thrombolytic therapy; chronic arterial obstruction; peripheral vascular disease; acute myocardial infarction; unstable angina; atrial fibrillation; thrombotic stroke; transient ischaemic attacks; restenosis and occlusion following angioplasty; or neurodegenerative disorders.
|
申请公布号 |
WO9513274(A1) |
申请公布日期 |
1995.05.18 |
申请号 |
WO1994EP03509 |
申请日期 |
1994.10.24 |
申请人 |
PFIZER LIMITED;PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A.;PFIZER INC.;DANILEWICZ, JOHN, CHRISTOPHER;ELLIS, DAVID;KOBYLECKI, RYSZARD, JUREK |
发明人 |
DANILEWICZ, JOHN, CHRISTOPHER;ELLIS, DAVID;KOBYLECKI, RYSZARD, JUREK |
分类号 |
A61K31/47;A61K31/55;A61K38/00;A61P7/02;A61P9/08;A61P9/10;C07D401/12;C07D401/14;C07K5/065;(IPC1-7):C07D401/12;A61K31/435 |
主分类号 |
A61K31/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|